Logo image of QS

QUANTUMSCAPE CORP (QS) Stock Fundamental Analysis

NYSE:QS - New York Stock Exchange, Inc. - US74767V1098 - Common Stock - Currency: USD

9.09  -0.35 (-3.71%)

After market: 9 -0.09 (-0.99%)

Fundamental Rating

2

QS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. The financial health of QS is average, but there are quite some concerns on its profitability. QS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QS had negative earnings in the past year.
QS had a negative operating cash flow in the past year.
QS had negative earnings in each of the past 5 years.
QS had a negative operating cash flow in each of the past 5 years.
QS Yearly Net Income VS EBIT VS OCF VS FCFQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -39.66%, QS is doing worse than 92.50% of the companies in the same industry.
QS has a worse Return On Equity (-45.21%) than 87.50% of its industry peers.
Industry RankSector Rank
ROA -39.66%
ROE -45.21%
ROIC N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
QS Yearly ROA, ROE, ROICQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

QS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QS Yearly Profit, Operating, Gross MarginsQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for QS has been increased compared to 1 year ago.
QS has a worse debt/assets ratio than last year.
QS Yearly Shares OutstandingQS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
QS Yearly Total Debt VS Total AssetsQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 17.45 indicates that QS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 17.45, QS belongs to the top of the industry, outperforming 98.75% of the companies in the same industry.
QS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, QS belongs to the top of the industry, outperforming 91.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 17.45
ROIC/WACCN/A
WACCN/A
QS Yearly LT Debt VS Equity VS FCFQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

QS has a Current Ratio of 16.40. This indicates that QS is financially healthy and has no problem in meeting its short term obligations.
QS has a better Current ratio (16.40) than 98.75% of its industry peers.
A Quick Ratio of 16.40 indicates that QS has no problem at all paying its short term obligations.
QS has a Quick ratio of 16.40. This is amongst the best in the industry. QS outperforms 98.75% of its industry peers.
Industry RankSector Rank
Current Ratio 16.4
Quick Ratio 16.4
QS Yearly Current Assets VS Current LiabilitesQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.47% over the past year.
EPS 1Y (TTM)9.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

QS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.80% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.09%
EPS Next 2Y9.28%
EPS Next 3Y16.02%
EPS Next 5Y18.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QS Yearly Revenue VS EstimatesQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
QS Yearly EPS VS EstimatesQS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QS. In the last year negative earnings were reported.
Also next year QS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QS Price Earnings VS Forward Price EarningsQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QS Per share dataQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

QS's earnings are expected to grow with 16.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.28%
EPS Next 3Y16.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUMSCAPE CORP

NYSE:QS (8/14/2025, 5:50:46 PM)

After market: 9 -0.09 (-0.99%)

9.09

-0.35 (-3.71%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners30.99%
Inst Owner Change0.34%
Ins Owners2.6%
Ins Owner Change5.36%
Market Cap5.15B
Analysts47.5
Price Target6.24 (-31.35%)
Short Float %16.3%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.85%
Min EPS beat(2)-1.22%
Max EPS beat(2)2.91%
EPS beat(4)2
Avg EPS beat(4)-0.25%
Min EPS beat(4)-6.33%
Max EPS beat(4)3.64%
EPS beat(8)4
Avg EPS beat(8)4.75%
EPS beat(12)4
Avg EPS beat(12)-3.85%
EPS beat(16)4
Avg EPS beat(16)-11.1%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)24.78%
PT rev (3m)11.68%
EPS NQ rev (1m)5%
EPS NQ rev (3m)5%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.02
P/tB 5.02
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0
BVpS1.81
TBVpS1.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.66%
ROE -45.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.4
Quick Ratio 16.4
Altman-Z 17.45
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)275.34%
Cap/Depr(5y)456.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y9.09%
EPS Next 2Y9.28%
EPS Next 3Y16.02%
EPS Next 5Y18.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.22%
EBIT Next 3Y13.67%
EBIT Next 5Y15.98%
FCF growth 1Y17.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.53%
OCF growth 3YN/A
OCF growth 5YN/A